These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 30600823)
21. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance. Ji X; Gao Y; Chen L; Zhang Z; Deng Y; Li Y Int J Pharm; 2012 Jan; 422(1-2):390-7. PubMed ID: 22001531 [TBL] [Abstract][Full Text] [Related]
22. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537 [TBL] [Abstract][Full Text] [Related]
23. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Wang Y; Yu L; Han L; Sha X; Fang X Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311 [TBL] [Abstract][Full Text] [Related]
24. Reducing Both Pgp Overexpression and Drug Efflux with Anti-Cancer Gold-Paclitaxel Nanoconjugates. Li F; Zhou X; Zhou H; Jia J; Li L; Zhai S; Yan B PLoS One; 2016; 11(7):e0160042. PubMed ID: 27467397 [TBL] [Abstract][Full Text] [Related]
25. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles. Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335 [TBL] [Abstract][Full Text] [Related]
26. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line. Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058 [TBL] [Abstract][Full Text] [Related]
27. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance. Jin X; Mo R; Ding Y; Zheng W; Zhang C Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological strategies for overcoming multidrug resistance. Nobili S; Landini I; Giglioni B; Mini E Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217 [TBL] [Abstract][Full Text] [Related]
29. Effects of Kampo medicines on MDR-1-mediated multidrug resistance in human hepatocellular carcinoma HuH-7/PTX cells. Hyuga S; Shiraishi M; Hori A; Hyuga M; Hanawa T Biol Pharm Bull; 2012; 35(10):1729-39. PubMed ID: 23037162 [TBL] [Abstract][Full Text] [Related]
30. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution. Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562 [TBL] [Abstract][Full Text] [Related]
31. Paclitaxel/hydroxypropyl-β-cyclodextrin complex-loaded liposomes for overcoming multidrug resistance in cancer chemotherapy. Shen Q; Shen Y; Jin F; Du YZ; Ying XY J Liposome Res; 2020 Mar; 30(1):12-20. PubMed ID: 30741058 [TBL] [Abstract][Full Text] [Related]
32. Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor. Che L; Liu Z; Wang D; Xu C; Zhang C; Meng J; Zheng J; Yuan H; Zhao G; Zhou X Acta Biomater; 2019 Oct; 97():461-473. PubMed ID: 31344512 [TBL] [Abstract][Full Text] [Related]
33. Charge-reversal-functionalized PLGA nanobubbles as theranostic agents for ultrasonic-imaging-guided combination therapy. Yang H; Shen X; Yan J; Xie X; Chen Z; Li T; Li S; Qin X; Wu C; Liu Y Biomater Sci; 2018 Aug; 6(9):2426-2439. PubMed ID: 30040100 [TBL] [Abstract][Full Text] [Related]
34. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Chavanpatil MD; Patil Y; Panyam J Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148 [TBL] [Abstract][Full Text] [Related]
35. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery. Hu L; Li M; Zhang Z; Shen Y; Guo S Int J Pharm; 2018 Dec; 553(1-2):510-521. PubMed ID: 30308274 [TBL] [Abstract][Full Text] [Related]
36. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
37. A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis. Mohammad IS; He W; Yin L Pharm Res; 2018 Feb; 35(4):77. PubMed ID: 29488114 [TBL] [Abstract][Full Text] [Related]
38. Anti-Cancer Efficacy of Paclitaxel Loaded in pH Triggered Liposomes. Jiang L; He B; Pan D; Luo K; Yi Q; Gu Z J Biomed Nanotechnol; 2016 Jan; 12(1):79-90. PubMed ID: 27301174 [TBL] [Abstract][Full Text] [Related]
39. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
40. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide. Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]